Summary sheet on Commission
Review (Ref XXIV/1288/97)
Ingredient:
1-amino-2-nitro-4-(ß-hydroxyethyl)amino-5-chloro-benzene
Function and max in use
concentration: oxidative
(permanent) max 2 %; 1 % with
H2O2 and semipermanent
(non-oxidative) max 2 % -
hair dye
Assessment of acute
toxicity (dermal, oral, i.v.,
i.p.):
Oral toxicity low
Assessment of irritation
& corrosivity:
No irritative or
corrosive effects on the skin
or mucous membranes in low
concentrations
Assessment of
chronic/subchronic toxicity:
Repeated dose toxicity
- 90 d oral application:
reasonable NOAEL
- 18-months dermal skin
painting study: no increased
tumour frequencies
Assessment of
reproductive toxicity:
No signs of maternal
toxicity, embryotoxicity or
teratogenicity within
reasonable dose ranges
Assessment of
genotoxicity/carcinogenicity:
No mutagenic properties
in appropriate in vitro tests
Assessment of
allergenicity/sensitization:
No sensitization or
primary irritation was observed
Percutaneous absorption:
In vitro testing
revealed a low penetration
rate, leading to an appropriate
"safety margin". Also the in
vivo investigations (with
radiolabelled test substance)
showed after oral or dermal
applications acceptable
results.
Classification: 1
Statement on the
toxicological evaluation
The SCCNFP is the
scientific advisory body to the
European Commission in matters
of consumer protection with
respect to cosmetics and
non-food products intended for
consumers.
The Commission's general
policy regarding research on
animals supports the
development of alternative
methods to reduce animal
testing when possible. In this
context, the SCCNFP has a
specific working group on
alternatives to animal testing
which, in co-operation with
other Commission services such
as ECVAM (European Centre for
Validation of Alternative
Methods), evaluates these
methods.
SCCNFP opinions include
evaluations of experiments
using laboratory animals; such
tests are conducted in
accordance with all legal
provisions and preferably under
chemical law regulations. Only
in cases where no alternative
method is available will such
tests be evaluated and the
resulting data accepted, in
order to meet the fundamental
requirements of the protection
of consumer health.